AARON JAMES MCCABE, D.O.
Marriage and Family Therapists at Valley Creek Rd, Saint Paul, MN

2009001, Jan 15, 2009

Jul 12, 2007

11/776744

Lahn M. Fendelander - Arlington MA, US
Lizbeth M. Mino - Northfield MN, US
Aaron R. McCabe - Minneapolis MN, US

CARDIAC PACEMAKERS, INC. - St. Paul MN

A61B 5/00

600301, 600486, 600529, 600547, 600595

A test system and method for cardiovascular autonomic neuropathy that incorporates an implanted medical device. One aspect of the invention relates to a system for performing cardiovascular autonomic neuropathy (CAN) testing in a diabetic patient having an implantable medical device (IMD) that includes a plurality of implantable physiological sensors and that is configured to transmit a wireless signal corresponding to a sensed physiological activity and to receive wireless signals. The system further includes one or more non-implantable physiological sensors, where the non-implantable physiological sensors are each configured to transmit a signal corresponding to a sensed physiological parameter, and a monitor device having a patient interface. The monitor device is configured to interface with a patient, including directing the patient to answer health related questions and use one or more of the non-implantable physiological sensors. The monitor device is also configured to receive signals, including signals from the IMD and the non-implantable physiological sensors. The system is configured to provide an indication of the presence or progression of CAN.

2010030, Dec 2, 2010

May 26, 2010

12/787557

Aaron R. McCabe - Minneapolis MN, US
Holly E. Rockweiler - Minneapolis MN, US
Jacob L. Laughner - St. Louis MO, US

A61N 1/36

607 11

The present invention concerns phrenic nerve activation detection algorithms for characterization of phrenic nerve activation and phrenic nerve activation avoidance in cardiac pacing therapy.Various embodiments concern receiving a respiration signal indicative of respiratory activity of the patient, identifying respiratory phases based on the respiration signal, delivering cardiac pacing pulses within each of the identified respiratory phases, receiving a phrenic nerve activation signal indicative of activation of the patient's phrenic nerve, analyzing the phrenic nerve stimulation signal to determine if one or more of the pacing pulses activated the phrenic nerve of the patient, and determining if at least one of the delivered pacing pulses activated the phrenic nerve of the patient based on the phrenic nerve activation signal indicating activation of the patient's phrenic nerve associated with delivery of the at least one cardiac pacing pulse.

2012030, Nov 29, 2012

Nov 29, 2011

13/306611

Yanting Dong - Lexington KY, US
Shibaji Shome - Arden Hills MN, US
Aaron McCabe - Minneapolis MN, US
Amy J. Brisben - St. Paul MN, US
Clayton Foster - Andover MN, US
David W. Yost - Brooklyn Park MN, US
Kenneth N. Hayes - Blaine MN, US

A61N 1/37, A61N 1/365

607 17, 607 28

Discrimination between different types of possible cardiac pacing responses may depend on the timing of expected features that are sensed within a temporal framework. The temporal framework may include classification intervals, blanking periods and appropriately timed back up paces. The classification intervals and blanking periods of the temporal framework are intervals of time that have time parameters that include start time, end time, and length. The relationships and timing parameters of the elements of the temporal framework, e.g., blanking periods, classification intervals, delay periods, and backup pacing, should support detection of features used to discriminate between different types of pacing responses. As the system learns the morphology of the particular patient by analyzing the waveform of the pacing response signal, the temporal framework for pacing response determination may be adjusted to accommodate the individual patient.

7797036, Sep 14, 2010

Mar 14, 2005

11/079744

Yi Zhang - Blaine MN, US
Scott A. Meyer - Rochester MN, US
Jeffrey E. Stahmann - Ramsey MN, US
Carlos Alberto Ricci - Apple Valley MN, US
Marina Brockway - Shoreview MN, US
Aaron R. McCabe - Minneapolis MN, US
Yinghong Yu - Shoreview MN, US
Donald I. Hopper - Maple Grove MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61B 5/04

600512

Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend ischemia using cardiac activation sequence information. Ischemia detection may involve sensing composite cardiac signals using implantable electrodes, and performing a signal separation that produces one or more cardiac activation signal vectors associated with one or more cardiac activation sequences. A change in the signal vector may be detected using subsequent separations. The change may be an elevation or depression of the ST segment of a cardiac cycle or other change indicative of myocardial ischemia, myocardial infarction, or other pathological change. The change may be used to predict, quantify, and/or qualify an event such as an arrhythmia, a myocardial infarction, or other pathologic change. Information associated with the vectors may be stored and used to track the vectors.

8401628, Mar 19, 2013

Jun 4, 2009

12/478476

Dan Li - Shoreview MN, US
Allan C. Shuros - St. Paul MN, US
Quan Ni - Shoreview MN, US
Aaron R. McCabe - Minneapolis MN, US
Yunlong Zhang - Mounds View MN, US
Jaeho Kim - Redmond WA, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61B 5/024

600515, 607 14

An apparatus comprises an implantable cardiac signal sensing circuit, configured to provide a sensed near-field depolarization signal from a ventricle and to provide a sensed a far-field intrinsic atrial signal using a far-field atrial sensing channel, and a controller circuit communicatively coupled to the cardiac signal sensing circuit. The controller circuit includes a P-wave detection module configured to detect an atrial depolarization in the sensed far-field intrinsic atrial signal and a tachyarrhythmia detection module configured to detect an episode of tachyarrhythmia using the sensed near-field depolarization signal and to determine whether the tachyarrhythmia episode is indicative of supraventricular tachycardia (SVT) using the detected atrial depolarization and the sensed near-field depolarization signal.

7299086, Nov 20, 2007

Mar 5, 2004

10/795126

Aaron McCabe - Minneapolis MN, US
Avram Scheiner - Vadnais Heights MN, US
Geng Zhang - Newbury Park CA, US
Quan Ni - White Bear Lake MN, US
Douglas R. Daum - Oakdale MN, US
Yi Zhang - Blaine MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61B 5/0428, A61N 1/368

600509, 607 9, 607 32, 607 36

An implantable medical device such as an implantable pacemaker or implantable cardioverter/defibrillator includes a programmable sensing circuit providing for sensing of a signal approximating a surface electrocardiogram (ECG) through implanted electrodes. With various electrode configurations, signals approximating various standard surface ECG signals are acquired without the need for attaching electrodes with cables onto the skin. The various electrode configurations include, but are not limited to, various combinations of intracardiac pacing electrodes, portions of the implantable medical device contacting tissue, and electrodes incorporated onto the surface of the implantable medical device.

7873413, Jan 18, 2011

Jul 24, 2006

11/459481

Aaron McCabe - Minneapolis MN, US
Imad Libbus - St. Paul MN, US
Yi Zhang - Blaine MN, US
Paul A. Haefner - Circle Pines MN, US
Alok S. Sathaye - Minneapolis MN, US
Anthony V. Caparso - St. Louis Park MN, US
M. Jason Brooke - Minneapolis MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/36

607 9, 607 7

Various aspects of the present subject matter relate to a method. According to various method embodiments, cardiac activity is detected, and neural stimulation is synchronized with a reference event in the detected cardiac activity. Neural stimulation is titrated based on a detected response to the neural stimulation. Other aspects and embodiments are provided herein.

8452405, May 28, 2013

May 3, 2010

12/772725

Eric Enrooth - Lino Lakes MN, US
Yanting Dong - Shoreview MN, US
Kenneth N. Hayes - Blaine MN, US
Gary T. Seim - Minneapolis MN, US
Kevin John Stalsberg - White Bear Lake MN, US
Aaron McCabe - Minneapolis MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/362

607 28, 607 9

Noncaptured atrial paces can result in long-short cardiac cycles which are proarrhythmic for ventricular tachyarrhythmia. Approaches are described which are directed to avoiding proarrhythmic long-short cycles. For cardiac cycles in which the atrial pace captures the atrium, a first post ventricular refractory period (PVARP) and a first A-A interval are used. For cardiac cycles in which the atrial pace does not capture the atrium, both an extended PVARP and an extended A-A interval are used. The A-A interval following a noncaptured atrial pace is extended from an atrial depolarization sensed during the extended PVARP.